
CEO of EMPE Diagnostics Global discusses the advanced diagnostic methods to combat tuberculosis (TB) in India. TB remains a major health issue associated with social stigma. India aims to eradicate TB by 2025, requiring investment in diagnostics and universal drug-susceptibility testing. EMPE has developed the mfloDxTM MDR-TB kit, recognized by the WHO, which can detect TB within 3 hours. The kit provides insights into the genotypic resistance profile of Mycobacterium tuberculosis. EMPE plans to focus on other infectious, non-communicable diseases and cancers.
Like
Save
Share